256 related articles for article (PubMed ID: 32134646)
21. Deep learning for molecular generation.
Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
[TBL] [Abstract][Full Text] [Related]
22. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
Griffen EJ; Dossetter AG; Leach AG; Montague S
Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
[TBL] [Abstract][Full Text] [Related]
23. Diversity in medicinal chemistry space.
Gorse AD
Curr Top Med Chem; 2006; 6(1):3-18. PubMed ID: 16454754
[TBL] [Abstract][Full Text] [Related]
24. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
25. De Novo Molecular Design with Chemical Language Models.
Grisoni F; Schneider G
Methods Mol Biol; 2022; 2390():207-232. PubMed ID: 34731471
[TBL] [Abstract][Full Text] [Related]
26. Improvement in ADMET Prediction with Multitask Deep Featurization.
Feinberg EN; Joshi E; Pande VS; Cheng AC
J Med Chem; 2020 Aug; 63(16):8835-8848. PubMed ID: 32286824
[TBL] [Abstract][Full Text] [Related]
27. Deep Learning Applied to Ligand-Based De Novo Drug Design.
Palazzesi F; Pozzan A
Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
[TBL] [Abstract][Full Text] [Related]
28. Enhancing reaction-based de novo design using a multi-label reaction class recommender.
Ghiandoni GM; Bodkin MJ; Chen B; Hristozov D; Wallace JEA; Webster J; Gillet VJ
J Comput Aided Mol Des; 2020 Jul; 34(7):783-803. PubMed ID: 32112286
[TBL] [Abstract][Full Text] [Related]
29. Learning Molecular Representations for Medicinal Chemistry.
Chuang KV; Gunsalus LM; Keiser MJ
J Med Chem; 2020 Aug; 63(16):8705-8722. PubMed ID: 32366098
[TBL] [Abstract][Full Text] [Related]
30. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
Lu F; Li M; Min X; Li C; Zeng X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
[TBL] [Abstract][Full Text] [Related]
31. De Novo Design at the Edge of Chaos.
Schneider P; Schneider G
J Med Chem; 2016 May; 59(9):4077-86. PubMed ID: 26881908
[TBL] [Abstract][Full Text] [Related]
32. Adversarial Threshold Neural Computer for Molecular de Novo Design.
Putin E; Asadulaev A; Vanhaelen Q; Ivanenkov Y; Aladinskaya AV; Aliper A; Zhavoronkov A
Mol Pharm; 2018 Oct; 15(10):4386-4397. PubMed ID: 29569445
[TBL] [Abstract][Full Text] [Related]
33. De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learning.
Ye G
J Comput Aided Mol Des; 2024 Apr; 38(1):20. PubMed ID: 38647700
[TBL] [Abstract][Full Text] [Related]
34. Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries.
Bian Y; Xie XQ
Cells; 2022 Mar; 11(5):. PubMed ID: 35269537
[TBL] [Abstract][Full Text] [Related]
35. Using deep neural networks to explore chemical space.
Vogt M
Expert Opin Drug Discov; 2022 Mar; 17(3):297-304. PubMed ID: 34918594
[TBL] [Abstract][Full Text] [Related]
36. The Synthesizability of Molecules Proposed by Generative Models.
Gao W; Coley CW
J Chem Inf Model; 2020 Dec; 60(12):5714-5723. PubMed ID: 32250616
[TBL] [Abstract][Full Text] [Related]
37. De novo molecular design with deep molecular generative models for PPI inhibitors.
Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
[TBL] [Abstract][Full Text] [Related]
38. Graph-based generative models for de Novo drug design.
Xia X; Hu J; Wang Y; Zhang L; Liu Z
Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
[TBL] [Abstract][Full Text] [Related]
39. Identification of Bioisosteric Substituents by a Deep Neural Network.
Ertl P
J Chem Inf Model; 2020 Jul; 60(7):3369-3375. PubMed ID: 32539382
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence approaches for rational drug design and discovery.
Duch W; Swaminathan K; Meller J
Curr Pharm Des; 2007; 13(14):1497-508. PubMed ID: 17504169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
